Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2026

Conditions
Critical Limb Ischemia
Interventions
PROCEDURE

UCA-PSCs/bFGF or bFGF Intramuscular injection

After skin disinfection, according to the distribution characteristics of blood vessels around the vascular lesion area, the site that is most likely to establish a new collateral circulation in vascular anatomy is selected. According to the vascular lesion of each subject, 40 reasonable injection sites are selected for Clusters of umbilical cord artery-derived perivascular stem cells with bFGF or bFGF only.

Trial Locations (1)

210008

RECRUITING

The affiliated Drum Towel Hospital of Nanjing University Medical School, Nanjing

All Listed Sponsors
lead

Nanjing University

OTHER